Stocks
Funds
Screener
Sectors
Watchlists

Latest Trium Capital LLP Stock Portfolio

Trium Capital LLP Performance:
2025 Q3: -2.45%YTD: -0.2%2024: 7.2%

Performance for 2025 Q3 is -2.45%, and YTD is -0.2%, and 2024 is 7.2%.

About Trium Capital LLP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Trium Capital LLP reported an equity portfolio of $255.8 Millions as of 30 Sep, 2025.

The top stock holdings of Trium Capital LLP are COOP, ACSG, BNDD. The fund has invested 15.4% of it's portfolio in MR COOPER GROUP ORD and 12.5% of portfolio in XTRCKR HRVST CSI 300 CHNA A SHR ETF.

The fund managers got completely rid off ISHARES MSCI CANADA ETF (ACWV), SPRINGWORKS THERAPEUTICS ORD (SWTX) and BLUEPRINT MEDICINES ORD (BPMC) stocks. They significantly reduced their stock positions in ISHARES MSCI BRAZIL ETF (ACWV), TRANE TECHNOLOGIES ORD (TT) and ITRON ORD (ITRI). Trium Capital LLP opened new stock positions in MR COOPER GROUP ORD (COOP), XTRCKR HRVST CSI 300 CHNA A SHR ETF (ACSG) and VERONA PHARMA ADR (VRNA). The fund showed a lot of confidence in some stocks as they added substantially to FIRST SOLAR ORD (FSLR), GREENBRIER ORD (GBX) and ENERSYS ORD (ENS).

Trium Capital LLP Annual Return Estimates Vs S&P 500

Our best estimate is that Trium Capital LLP made a return of -2.45% in the last quarter. In trailing 12 months, it's portfolio return was -1.5%.

New Buys

Ticker$ Bought
mr cooper group ord39,460,100
xtrckr hrvst csi 300 chna a shr etf31,954,900
verona pharma adr10,653,600
ishares msci emerging markets etf10,183,400
taskus cl a ord7,215,100
pentair ord1,388,160
theratechnolgies ord1,080,830
darling ingredients ord871,090

New stocks bought by Trium Capital LLP

Additions to existing portfolio by Trium Capital LLP

Reductions

Ticker% Reduced
ishares msci brazil etf-49.87
trane technologies ord-49.13
ishares msci south korea etf-45.46
itron ord-41.26
wabtec ord-27.84
albertsons companies cl a ord-20.05
kraneshares csi china internet etf-17.25
bluerock homes trust cl a ord-13.59

Trium Capital LLP reduced stake in above stock

Sold off

Ticker$ Sold
inozyme pharma ord-12,693,800
playags ord-23,284,400
ishares msci canada etf-71,725,900
vaneck vietnam etf-13,600,500
springworks therapeutics ord-37,002,700
redfin ord-8,220,260
equinox gold ord-3,784,530
akoya biosciences ord-787,145

Trium Capital LLP got rid off the above stocks

Sector Distribution

Trium Capital LLP has about 55.3% of it's holdings in Others sector.

Sector%
Others55.3
Financial Services15.5
Consumer Defensive8.5
Industrials8.4
Healthcare6.1
Technology4.5

Market Cap. Distribution

Trium Capital LLP has about 17% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED55.6
MID-CAP21.9
LARGE-CAP17
SMALL-CAP4.8

Stocks belong to which Index?

About 24.7% of the stocks held by Trium Capital LLP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others75.3
RUSSELL 200018.5
S&P 5006.2
Top 5 Winners (%)%
NVT
nvent electric ord
23.9 %
AYI
acuity ord
12.5 %
ENS
enersys ord
11.2 %
BLD
topbuild ord
10.6 %
XYL
xylem ord
8.7 %
Top 5 Winners ($)$
NVT
nvent electric ord
0.5 M
BLD
topbuild ord
0.2 M
AYI
acuity ord
0.2 M
XYL
xylem ord
0.1 M
ENS
enersys ord
0.1 M
Top 5 Losers (%)%
ACI
albertsons companies cl a ord
-18.6 %
QTRX
quanterix ord
-16.1 %
CNHI
cnh industrial ord
-10.2 %
CWEN
clearway energy cl a ord
-7.2 %
ITRI
itron ord
-5.4 %
Top 5 Losers ($)$
ACI
albertsons companies cl a ord
-6.0 M
QTRX
quanterix ord
-0.7 M
CNHI
cnh industrial ord
-0.1 M
WAB
wabtec ord
-0.1 M
RSG
republic services ord
-0.1 M

Trium Capital LLP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Trium Capital LLP

Trium Capital LLP has 48 stocks in it's portfolio. About 80.9% of the portfolio is in top 10 stocks. ACI proved to be the most loss making stock for the portfolio. NVT was the most profitable stock for Trium Capital LLP last quarter.

Last Reported on: 16 Oct, 2025
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions